The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Selexipag · SELEXIPAG 400 ug/1 · Tablet, Film Coated · Oral · Zydus Pharmaceuticals (USA) Inc.
NDC 70710-1552-06 · 60 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | SELEXIPAG 150 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Actelion Pharmaceuticals US, Inc. | SELEXIPAG 100 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 400 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 1200 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 600 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 800 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 1600 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 200 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 1000 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | SELEXIPAG 1400 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 800 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 1000 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 1200 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 1400 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 1600 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 200 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 400 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | SELEXIPAG 600 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Selexipag — NDC 70710-1552-06," retrieved September 3, 2026, https://drugdashboards.com/drug/70710155206.
Free to cite with attribution — see how the data is put together.